Drivers of disease severity and burden of hidradenitis suppurativa: a cross‐sectional analysis on 553 German patients

A centre-based, ambulatory care concept for Hidradenitis suppurativa improves disease activity, burden, and patient satisfaction: results from the randomised controlled trial EsmAiL

(2023) Michael Schultheis et al.   BRITISH JOURNAL OF DERMATOLOGY

Prevalence of Depression among Children, Adolescents, and Adults with Hidradenitis Suppurativa

(2021) Shari Wright et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty‐six‐week phase 3 open‐label study

(2020) Kenshi Yamasaki et al.   JOURNAL OF DERMATOLOGY

Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis

(2020) Matthias Augustin et al.   JAMA Dermatology

Evaluating Patients’ Unmet Needs in Hidradenitis Suppurativa: results from the Global VOICE project

(2019) Amit Garg et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States

(2018) Amit Garg et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Impact of Hidradenitis Suppurativa on Work Loss, Indirect Costs and Income

(2018) T Tzellos et al.   BRITISH JOURNAL OF DERMATOLOGY

Association of Low Socioeconomic Status With Hidradenitis Suppurativa in the United States

(2018) Sara Wertenteil et al.   JAMA Dermatology

Hidradenitis Suppurativa

(2017) Ditte Marie Lindhardt Saunte et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pain in Hidradenitis Suppurativa: A Pilot Study

(2016) H Ring et al.   ACTA DERMATO-VENEREOLOGICA

Self-reported pain management in hidradenitis suppurativa

(2016) H.C. Ring et al.   BRITISH JOURNAL OF DERMATOLOGY

Establishment of cutpoints to categorize the severity of chronic pain using composite ratings with Rasch analysis

(2016) C.-W. Chien et al.   EUROPEAN JOURNAL OF PAIN

Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study

(2016) Inge E. Deckers et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa

(2016) Alexander Egeberg et al.   JAMA Dermatology

Depression und Angststörung bei Psoriasispatienten

(2014) K. Bangemann et al.   HAUTARZT

Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity

(2014) Anne M.R. Schrader et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

S1-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa* (ICD-10 Ziffer: L73.2)

(2012) Christos C. Zouboulis et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

A psychometric evaluation of the Hospital Anxiety and Depression Scale for the medically hospitalized elderly

(2011) Anne-Sofie Helvik et al.   NORDIC JOURNAL OF PSYCHIATRY

Hidradenitis suppurativa markedly decreases quality of life and professional activity

(2010) Łukasz Matusiak et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

(2008) M.K.A. Basra et al.   BRITISH JOURNAL OF DERMATOLOGY